Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Peetermans

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.
Haematology and Blood Transfusion|January 1, 1987
Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791)P Stryckmans, J P Marie, S Suciu, et al.
Leukemia|January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study GroupP Stryckmans, T De Witte, J P Marie, et al.
Seminars in Oncology|June 1, 1987
Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemiaP Stryckmans, T De Witte, N Bitar, et al.
Bone Marrow Transplantation|August 1, 1997
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trialR Zittoun, S Suciu, M Watson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2015
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disordersM Jacquemin, J Toelen, J Schoeters, et al.
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of CancerA D Ho, S Suciu, P Stryckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative GroupA D Ho, S Suciu, P Stryckmans, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupR Zittoun, S Suciu, F Mandelli, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.
Haematology and Blood Transfusion|January 1, 1987
Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791)P Stryckmans, J P Marie, S Suciu, et al.
Leukemia|January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study GroupP Stryckmans, T De Witte, J P Marie, et al.
Seminars in Oncology|June 1, 1987
Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemiaP Stryckmans, T De Witte, N Bitar, et al.
Bone Marrow Transplantation|August 1, 1997
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trialR Zittoun, S Suciu, M Watson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2015
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disordersM Jacquemin, J Toelen, J Schoeters, et al.
Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of CancerA D Ho, S Suciu, P Stryckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative GroupA D Ho, S Suciu, P Stryckmans, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupR Zittoun, S Suciu, F Mandelli, et al.
Pageof 5